Equity · Healthcare
IDXX
NASDAQIDEXX Laboratories (IDXX)
The line runs 568 USD on 3 August through 551.48 USD on 30 October, on a scale from 500 to 600. Days the market did not trade hold the previous close, flat.
- Market cap
- 43.4B USD
- P/E (TTM)
- 38.8
- Revenue, year to Dec 2025
- 4.3B USD
- EPS, diluted, year to Dec 2025
- 13.08 USD
- 52-week range
- 505 USD – 766.67 USD
- Avg volume
- 34.3K
- Mentions, 30 days
- 1
as of Oct 30, 2026
Have IDEXX Laboratories (IDXX) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, IDEXX Laboratories insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 7 Nov 2025, show no open-market purchase.
Form 4, 90 days to 1 Nov 2026, newest reported trade 4 Sep 2026
Buys 0Sells 1Net sold $1.17MOther filings 3
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Sep 2026 | Kingsley Lawrence DDirector | Sell | 2,203 | 1.2M USD |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Sep 2026 | Kingsley Lawrence DDirector | Option exercise | 2,203 | 252K USD |
| 20 Aug 2026 | Emerson AndrewEVP, CFO and Treasurer | Option exercise | 265 | 47K USD |
| 20 Aug 2026 | Emerson AndrewEVP, CFO and Treasurer | Tax withheld | 86 |
Which funds hold IDEXX Laboratories (IDXX)?
11 of the 45 institutional funds we track reported a IDEXX Laboratories position for the quarter ended 30 Jun 2026 — a combined 930.7M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fundsmith | Trimmed | 1,019,887 | 536.9M USD | −30.4% |
| Point72 Asset Management | Added | 262,905 | 138.4M USD | +103.4% |
| Renaissance Technologies | Added | 109,784 | 57.8M USD | +126.3% |
| Marshall Wace | Added | 93,128 | 49.0M USD | +88.9% |
| Millennium Management | Held (±25%) | 78,980 | 41.6M USD | +12.1% |
| AQR Capital Management | Held (±25%) | 77,198 | 40.4M USD | −20.2% |
| Man Group | Added | 51,382 | 27.0M USD | +48.8% |
| Citadel Advisors | Trimmed | 38,846 | 20.5M USD | −55.6% |
| Bridgewater Associates | Added | 33,528 | 17.7M USD | +225.1% |
| Balyasny Asset Management | Added | 1,808 | 952K USD | +38.2% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded IDEXX Laboratories (IDXX)?
The most recent congressional trade disclosed in IDEXX Laboratories is a sale by April McClain Delaney (house, MD), dated 16 Oct 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 16 Oct 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 19 days |
| 04 Sep 2025 | Byron Donaldshouse · Republican–FL | Purchase | 1K USD–15K USD | 33 days |
| 07 Aug 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 26 days |
| 09 Jul 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 27 days |
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 25 days |
| 12 May 2025 | Jefferson Shrevehouse · Republican–IN | Sale | 100K USD–250K USD | 41 days |
| 09 Apr 2025 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 23 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 20 days |
IDEXX Laboratories (IDXX) US federal contracts
US federal agencies committed 1.8M USD in contracts to IDEXX Laboratories (IDXX) in fiscal 2026, the year to 30 Sep 2026, against 1.6M USD the year before.
USAspending.gov
Fiscal 2026 1.8M USDFiscal 2025 1.6M USDFiscal 2024 1.8M USDFiscal 2023 1.3M USD
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 11 Jun 2026 | National Institutes of HealthDepartment of Health and Human Services | OD: SERVICE: ANIMAL HEALTH & DIAGNOSTIC TESTING SERVICES - SEVERABLESUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00001 · IDEXX DISTRIBUTION, INC | 594K USD |
| 10 Apr 2026 | National Institutes of HealthDepartment of Health and Human Services | IDEXX DISTRIBUTION, INC.:1254707 [26-000422]SUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00002 · IDEXX DISTRIBUTION, INC | 390K USD |
| 17 Mar 2026 | Animal and Plant Health Inspection ServiceDepartment of Agriculture | 190 PRV ELISA GB STRIP KITS (P/N 99-09732)LABORATORY EQUIPMENT AND SUPPLIES · 12639526F0321 · IDEXX DISTRIBUTION, INC | 153K USD |
| 28 Jan 2026 | Department of the NavyDepartment of Defense | REAGENT POWDERLABORATORY EQUIPMENT AND SUPPLIES · N0010426PBH04 | 103K USD |
| 15 Dec 2025 | National Institutes of HealthDepartment of Health and Human Services | CONTRACT FOR SEROLOGY AND PCR ASSAY TESTING SERVICESSUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00001 · IDEXX DISTRIBUTION, INC | 230K USD |
| 23 Sep 2025 | Agricultural Research ServiceDepartment of Agriculture | IDEXX SWINE INFLUENZA VIRUS AB TESTS.LABORATORY EQUIPMENT AND SUPPLIES · 1232SA25P0452 | 111K USD |
| 21 Aug 2025 | National Institutes of HealthDepartment of Health and Human Services | CONTRACT FOR SEROLOGY AND PCR ASSAY TESTING SERVICESSUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98025F00010 · IDEXX DISTRIBUTION, INC | 185K USD |
| 20 Mar 2025 | Animal and Plant Health Inspection ServiceDepartment of Agriculture | PRV ELISA GB STRIP KITS (P/N99-09732) FOR KY BRUCELLOSIS LAB (ORDERING PERIOD 2)LABORATORY EQUIPMENT AND SUPPLIES · 12639525F0504 · IDEXX DISTRIBUTION, INC | 147K USD |
| 26 Feb 2025 | National Institutes of HealthDepartment of Health and Human Services | PATHOLOGY MONITORING OF AGED RODENT COLONIESSPECIAL STUDIES/ANALYSIS- ANIMAL/FISHERIES · 75N95025F00001 · IDEXX DISTRIBUTION, INC | 171K USD |
| 18 Nov 2024 | National Institutes of HealthDepartment of Health and Human Services | IDEXX DISTRIBUTION, INC.:1254707 [25-000518]SUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98025F00002 · IDEXX DISTRIBUTION, INC | 109K USD |
Newest first: 10 of 15 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for IDEXX Laboratories (IDXX)?
The filings we hold for IDEXX Laboratories, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 06 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 3 shares | 2K USD notional · <0.001% of shares out |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 31 shares | 16K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 4.27 USD | Revenue $1.22B |
| 30 Jun 2026 | Financials | Total assets | 3.4B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 1.6B USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.47 USD | Revenue $1.14B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 13.08 USD | Revenue $4.30B |
| 31 Dec 2025 | Financials | Revenue | 4.3B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 13.08 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 3.40 USD | Revenue $1.11B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 3.63 USD | Revenue $1.11B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.96 USD | Revenue $998M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 10.67 USD | Revenue $3.90B |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 2.80 USD | Revenue $976M |
What is Reddit saying about IDEXX Laboratories (IDXX)?
Reddit mentioned IDXX 1 times in the 30 days to 1 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 1 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How do Reddit mentions of IDEXX Laboratories (IDXX) compare with its price?
Share ↗
Where IDEXX Laboratories (IDXX) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 100% | 1 | +0.24 |
IDEXX Laboratories (IDXX): frequently asked questions
What did IDEXX Laboratories shares close at?
IDEXX Laboratories closed at 551.48 USD on 30 Oct 2026, down 4.25% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is IDEXX Laboratories’ market cap?
IDEXX Laboratories is worth 43.4B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is IDEXX Laboratories’ P/E ratio?
IDEXX Laboratories has a price-to-earnings ratio of 38.8, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is IDEXX Laboratories’ revenue?
IDEXX Laboratories reported revenue of 4.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have IDEXX Laboratories insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, IDEXX Laboratories insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 7 Nov 2025, show no open-market purchase. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own IDEXX Laboratories?
11 of the 45 funds we track reported a IDEXX Laboratories position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fundsmith, Point72 Asset Management and Renaissance Technologies. See Funds
Have members of Congress traded IDEXX Laboratories?
Yes. 14 trades in IDEXX Laboratories appear in the congressional disclosures we hold; the latest is a sale by April McClain Delaney (House, MD) dated 16 Oct 2025, filed 4 Nov 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did IDEXX Laboratories last report earnings?
IDEXX Laboratories last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 4.27 USD; no next date is announced in SEC filings yet. See Filings
Does IDEXX Laboratories have government contracts?
Yes. US federal agencies committed 1.8M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about IDEXX Laboratories?
IDEXX Laboratories was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Idexx_Laboratories